Lineage Cell Therapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $14 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Lineage Cell Therapeutics is raising $14,000,000.00 in new funding. About Lineage Cell Therapeutics: Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies…